Your browser doesn't support javascript.
loading
Complement gene variant effect on relapse of complement-mediated thrombotic microangiopathy after eculizumab cessation.
Acosta-Medina, Aldo A; Moyer, Ann M; Go, Ronald S; Willrich, Maria Alice V; Fervenza, Fernando C; Leung, Nelson; Bourlon, Christianne; Winters, Jeffrey L; Spears, Grant M; Bryant, Sandra C; Sridharan, Meera.
Affiliation
  • Acosta-Medina AA; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Moyer AM; Department of Internal Medicine, Mayo Clinic, Rochester, MN.
  • Go RS; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
  • Willrich MAV; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Fervenza FC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
  • Leung N; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.
  • Bourlon C; Division of Hematology, Mayo Clinic, Rochester, MN.
  • Winters JL; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN.
  • Spears GM; Department of Hematology and Oncology, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico.
  • Bryant SC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN.
  • Sridharan M; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN.
Blood Adv ; 7(3): 340-350, 2023 02 14.
Article in En | MEDLINE | ID: mdl-35533258

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Thrombotic Microangiopathies Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Blood Adv Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Kidney Transplantation / Thrombotic Microangiopathies Type of study: Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Blood Adv Year: 2023 Document type: Article